188 related articles for article (PubMed ID: 34198234)
1. A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
Patel KB; Mroz EA; Faquin WC; Rocco JW
Oral Oncol; 2021 Sep; 120():105421. PubMed ID: 34198234
[TBL] [Abstract][Full Text] [Related]
2. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
Mroz EA; Patel KB; Rocco JW
Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
[TBL] [Abstract][Full Text] [Related]
3. Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
Koenigs MB; Lefranc-Torres A; Bonilla-Velez J; Patel KB; Hayes DN; Glomski K; Busse PM; Chan AW; Clark JR; Deschler DG; Emerick KS; Hammon RJ; Wirth LJ; Lin DT; Mroz EA; Faquin WC; Rocco JW
J Natl Cancer Inst; 2019 Sep; 111(9):933-942. PubMed ID: 30715409
[TBL] [Abstract][Full Text] [Related]
4. Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
Mroz EA; Tward AD; Hammon RJ; Ren Y; Rocco JW
PLoS Med; 2015 Feb; 12(2):e1001786. PubMed ID: 25668320
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
[TBL] [Abstract][Full Text] [Related]
6. Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.
Drake V; Bigelow E; Fakhry C; Windon M; Rooper LM; Ha P; Miles B; Gourin C; Mandal R; Mydlarz W; London N; Vosler PS; Yavvari S; Troy T; Waterboer T; Eisele DW; D'Souza G
Oral Oncol; 2021 Oct; 121():105461. PubMed ID: 34304004
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
8. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
10. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.
Mroz EA; Rocco JW
Oral Oncol; 2013 Mar; 49(3):211-5. PubMed ID: 23079694
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Bristol ML; James CD; Wang X; Fontan CT; Morgan IM
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188745
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
16. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Eder T; Hess AK; Konschak R; Stromberger C; Jöhrens K; Fleischer V; Hummel M; Balermpas P; von der Grün J; Linge A; Lohaus F; Krause M; Baumann M; Stuschke M; Zips D; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Budach V; Tinhofer I;
Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
[TBL] [Abstract][Full Text] [Related]
17.
Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
[TBL] [Abstract][Full Text] [Related]
18. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
19. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.
Mroz EA; Tward AD; Pickering CR; Myers JN; Ferris RL; Rocco JW
Cancer; 2013 Aug; 119(16):3034-42. PubMed ID: 23696076
[TBL] [Abstract][Full Text] [Related]
20. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
